Abstract:Hypertension is a serious public health problem worldwide. MT-1207, chemically named 3-(4-(4-(1H-benzotriazole-1-yl)butyl)piperazine-1-yl) benzisothiazole hydrochloride, is a new chemical entity that has entered into clinical trial as antihypertensive agent in China. In this paper we report the pharmacological profile of MT-1207 regarding its acute, subacute, and long-term effects on hypertensive animal models, and its actions on isolated organs in vitro as well as its molecular targets. Blood pressure (BP) was measured in conscious animals; amlodipine was taken as a positive control drug. We showed that both single dose of MT-1207 (1.25−20 mg/kg, ig) in spontaneously hypertensive rats (SHR) and MT-1207 (0.25−6 mg/kg, ig) in two-kidney one-clip (2K1C) dogs dose-dependently decreased BP. MT-1207 quickly decreased BP within 5 min after administration; the hypotensive effect lasted for 8 and 12 h, respectively, in SHR and 2K1C dogs without reflex increase in heart rate. Multiple doses of MT-1207 (5 mg · kg−1 · d−1 in SHR; 2 mg · kg−1 · d−1 in 2K1C dogs, for 7 days) significantly decreased BP, slightly reduced heart rate, and both of them recovered after withdrawal. Long-term administration of MT-1207 (10 mg · kg−1 · d−1 for 4 months or more time) produced a stable BP reduction, improved baroreflex sensitivity, reduced renal and cardiovascular damage in SHR, and delayed stroke occurrence and death in stroke-prone SHR. In isolated rat aortic rings precontracted by adrenaline, KCl, noradrenaline or 5-hydroxytryptamine (5-HT), MT-1207 (10−9–10−4 M) caused concentration-dependent relaxation. In a panel of enzyme activity or radioligand binding assays of 87 molecular targets, MT-1207 potently inhibited adrenergic α1A, α1B, α1D, and 5-HT2A receptors with Ki < 1 nM. The antagonism of MT-1207 against these receptors was confirmed in isolated rabbit arteries. We conclude that MT-1207 is a novel and promising single-molecule multitarget agent for hypertension treatment to reduce hypertensive organ damage and stroke mortality.

Hypotensive Activity of Tetrandrine in Rats

Hypotensive activity of tetrandrine in rats. Investigation into its mode of action.

Tetrandrine, an Alkaloid from S. Tetrandra Exhibits Anti-Hypertensive and Sleep-Enhancing Effects in SHR Via Different Mechanisms.

Tetrandrine, an Antihypertensive Alkaloid, Improves the Sleep State of Spontaneously Hypertensive Rats (Shrs).

Vasodilating and hypotensive effects of fangchinoline and tetrandrine on the rat aorta and the stroke-prone spontaneously hypertensive rat

Efficacy of tetrandrine on lowering intraocular pressure in animal model with ocular hypertension.

[Hypotensive Effect of 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino) Propane Hydrochloride].

Influence of Hypertension on Tetrahydropapaveroline-Induced Vasorelaxation in Rat Thoracic Aorta.

Tetrandrine inhibits aldosterone synthesis by covalently targeting CYP11A1 to attenuate hypertension

Tetrandrine is Not a Selective Calcium Channel Blocker in Vascular Smooth Muscle.

Pharmacological characterization of MT-1207, a novel multitarget antihypertensive agent

Ketanserin Stabilizes Blood Pressure in Conscious Spontaneously Hypertensive Rats

The beta adrenoceptor blocker tertatolol causes vasodilatation in the isolated perfused vasoconstricted rat kidney

Intraocular Pressure-Lowering Effect of Tetrandrine and Timolol on Rats with Ocular Hypertension

Effects of Green Tea on Blood Pressure and Hypertension-Induced Cardiovascular Damage in Spontaneously Hypertensive Rat

Diminished Cardiac Contractile Response to Tetrahydropapaveroline in Hypertension: Role of Β-Adrenoceptors and Intracellular Ca2+

Effects of six antihypertensive drugs on blood pressure and hypothalamic GABA content in spontaneously hypertensive rats.

[Preventive Effects of Tetrandrine on Pulmonary Hypertension and Right Ventricular Hypertrophy in Rats Induced by Monocrotaline].

Hypotensive effects and mechanisms of adrenomendullin(13-52)

The Hypotensive Effect of Intrathecally Injected (M)vd-Hemopressin(α) in Urethane-Anesthetized Rats.

The Experimental Study of Decrease Blood Pressure with MN9202